Mandate

Vinge advises the majority shareholders Altor, Telia Company, Time For Growth and Zenith VC in the divestment of shares in Marshall Group

Vinge advises the majority shareholders Altor, Telia Company, Time For Growth and Zenith VC in connection with the divestment of shares in Marshall Group AB (publ) (”Marshall Group”) to HongShan Group, formerly known as Sequoia China. The Marshall Family will continue as owner in the Marshall Group.

Marshall Group is the audio, tech and design powerhouse uniting musicians and music lovers through genre-breaking innovation. Marshall, the flagship brand, is uniquely positioned with over 60 years of rock’n’roll attitude on stage, at home, and on the go, across more than 90 markets. Marshall Group has more than EUR 400 million in revenues and brings together around 800 talented people across eight locations globally.

The transaction is subject to applicable antitrust approvals.

Vinge’s team consisted of Christina Kokko, Johanna Wiberg, Elsie Nassar, Ellinor Wargenbrant and Emma Lundberg (M&A), David Andersson and Joel Magnusson (Capital Markets & Public M&A), Albert Wållgren, Karl-Gustaw Tobola and William Carlberg Johansson (Banking & Finance), Rebecka Målquist (Intellectual Property), Martin Boström and Mario Saad (Commercial Agreements), Carla Håkansson and Siri Blomberg (IT and GDPR), Emil Lindwall (Employment and Benefits), Hayaat Ibrahim and Gulestan Ali (Compliance), Hanna Kövamees (Real Property and Environment), Marcus Glader, Sebastian Örndahl, Lovisa Lewin and Alva Chambert (EU, Competition and Regulatory), Ellinore Boström Andersson, Cecilia Loctander, Emelie Schoning and Gabriella Balbo (Transaction Support Coordinators).

Read the press release.

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025